Skin canceris among one of the known health problems among people around the world as well as in Malaysia where cancer is among the Top diseases in malaysia. This is mainly due to the fact that while many are aware of the risks, many are unaware of how much they are exposed to them.
Regular sun exposure or other forms of ultraviolet radiation will cause basal cell carcinoma which is a common type of skin cancer. This is where the problem starts at the epidermis, the top layer of the skin and grows very slowly and silently until its too late.
A new drug called Erivedge was recently approved by the US Food and Drug Administration where it can be used to treat adults with this health problem. It is specifically designed for those who have this cancer that has spread to other parts of the body where they are unable to use surgery or radiation for treatment.
Erivedge is made in the form of a pill that can be taken daily. It is the agent that will block what is known as the Hedgehog pathway known to be responsible for most basal cell cancers. However, as with drugs used for serious diseases like these, there are several side effects that the patient might experience which would include hair and weight loss, diarrhea, vomiting, constipation, loss of taste and fatigue, among others.
The drug is marketed by Genentech which is part of the Roche Group and is a prescribed drug especially for women as there are implications on pregnancy with birth effects after consumption.